Zydus Lifesciences Ltd
₹1105.90
+6.90
(+0.63%)
as on
What are INDmoney investors doing with Zydus Lifesciences shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-25%
Searches for Zydus Lifesciences on INDmoney have decreased by 25% over the last 30 days.
Investment activity on INDmoney
-7.80%
Investment activity in Zydus Lifesciences among INDmoney users has decreased by 7.80% over the last 30 days.
Among the most traded stocks
315th
Zydus Lifesciences was the 315th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
54 days
INDmoney investors hold Zydus Lifesciences shares for an average of 54 days.
Key Events for Zydus Lifesciences
Zydus Lifesciences Stock Performance
as on September 16, 2026 at 6:28 pm IST
Day's Low
Day's High
₹1,086.00₹1,109.70
1.80%
Downside
0.34%
Upside
52 Week's Low
52 Week's High
₹835.50₹1,205.0024.45%
Downside
8.96%
Upside
Zydus Lifesciences share price movements today
- Previous Close
- ₹1,099.00
- Open
- ₹1,107.00
- Volume
- 4.00L
- Upper Circuit
- ₹1,208.90
- Lower Circuit
- ₹989.10
- Day's Low - High
- ₹1,086.00 - ₹1,109.70
- 52 Week Low - High
- ₹835.50 - ₹1,205.00
Zydus Lifesciences Historical Returns
- 1 Month Return
- -2.87 %
- 3 Month Return
- + 1.88 %
- 1 Year Return
- + 6.23 %
- 3 Year Return
- + 70.81 %
- 5 Year Return
- + 94.69 %
Zydus Lifesciences Fundamentals
as on September 16, 2026 at 12:58 pm IST
Market Cap
₹1,09,625.67 Cr
Return on Equity (ROE)
15.87
PE Ratio (TTM)
24.94
Return on capital employed (ROCE)
15.9
Industry PE ratio
51.81
Beta (LTM)
0.66
P/B Ratio
3.7
Dividend Yield
0PEG Ratio
-43
Quarterly Earnings Growth YOY
-35.93
EPS (TTM)
49.96
Book Value
269.5
Zydus Lifesciences Stock Valuation
as on September 16, 2026 at 12:58 pm IST
Zydus Lifesciences in the last 5 years
Lowest (7.34x)
March 7, 2022
Today (24.94x)
September 11, 2026
Industry (51.81x)
September 11, 2026
Highest (34.62x)
March 26, 2024
Today’s Price to Earnings Ratio: 24.94x
Zydus Lifesciences Technical Analysis
Track how Zydus Lifesciences technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.55 | Bullish |
CCI (20) | -447.41 | Bullish |
RSI (14) | 68.45 | Neutral |
Momentum (10) | 2.6 | Bullish |
ADI (14) | 29.4 | Bullish |
Ultimate Oscillator (7,14,28) | 84.63 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 1106.64 | Bullish |
EMA (20) | 1106.73 | Bullish |
VWMA (20) | 1106.84 | Bullish |
SMA (50) | 1106.14 | Bullish |
EMA (50) | 1105.23 | Bullish |
SMA (200) | 1098.9 | Bullish |
EMA (200) | 1101.55 | Bullish |
KAMA (200) | 1106.66 | Bullish |
DEMA (200) | 1101.93 | Bullish |
Zydus Lifesciences Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 1,09,625.67 | 18.94% | 0.69 | 5,026 | 51,180 | |
| BUY | 7,210.69 | -12.22% | 0.00 | 413 | 2,013 | |
| BUY | 95,512.73 | 23.99% | 0.60 | 3,502 | 33,653 | |
| BUY | 55,515.63 | 4.88% | 0.00 | 1,414 | 6,445 | |
| BUY | 47,753.87 | 15.84% | 0.56 | 1,035 | 3,821 |
Market expectation of Zydus Lifesciences Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
51.72%
Buy
24.14%
Hold
24.14%
Sell
Zydus Lifesciences Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Annual Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Zydus Lifesciences
Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Zydus Lifesciences
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
 HSBC Midcap Fund Direct Plan Growth | ₹324.36 Cr | ₹146.31 Cr (+82.17%) | 1.98% |
 Bandhan Large & Mid Cap Fund Direct Plan Growth | ₹203.62 Cr | ₹88.33 Cr (+76.61%) | 1.05% |
Mutual Funds Exiting Zydus Lifesciences
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
 ICICI Prudential Large Cap Fund Direct Plan Growth | ₹274.38 Cr | ₹36.31 Cr (-11.69%) | 0.36% |
Zydus Lifesciences Corporate Actions
View detailed summary of the earnings and dividend history of Zydus Lifesciences.
Zydus Lifesciences Ltd Earnings Results
Zydus Lifesciences Ltd’s net profit fell -35.93% since last year same period to ₹939.80Cr in the Q1 2026-2027. On a quarterly growth basis, Zydus Lifesciences Ltd has generated -26.15% fall in its net profits since last 3-months.
Read More about Earnings ResultsZydus Lifesciences Ltd Dividends May,2026
In the quarter ending March 2026, Zydus Lifesciences Ltd has declared dividend of ₹1.00 per share on 19 May 2026 - translating a dividend yield of 0.09%.
Read More about Dividends
Indices Featuring Zydus Lifesciences Stock
Check stock indices that include Zydus Lifesciences.
Insights on Zydus Lifesciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 75.00% to 75.01% in Jun 2026 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 6.23K Cr → 8.12K Cr (in ₹), with an average increase of 8.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, ZYDUSLIFE stock has moved up by 23.9%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 4.88% to 5.12% in Jun 2026 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 86.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 44.6%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 6.95% to 6.88% in Jun 2026 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 1.27K Cr → 939.8 Cr (in ₹), with an average decrease of 26.2% per quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 6.86% to 6.83% in Jun 2026 quarter
Zydus Lifesciences Stock Futures & Options Contracts
View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.
Zydus Lifesciences Options
Zydus Lifesciences Futures
About Zydus Lifesciences Ltd
The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.
Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.
Revenue: ₹7,802.00Cr as on June 2026 (Q1 FY27)
Net Profit: ₹952.40Cr as on June 2026 (Q1 FY27)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
| Organisation | Zydus Lifesciences Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Pankaj R Patel |
| E-voting on shares | Click here to vote |
FAQs
What is Zydus Lifesciences share price today?
Zydus Lifesciences share price today stands at ₹1105.9 as on . Zydus Lifesciences share today touched a day high of ₹1109.7 and a low of ₹1086.
What is the 52 week high and 52 week low range for Zydus Lifesciences share?
Zydus Lifesciences touched a 52 week high of ₹1205 and a 52 week low of ₹835.5. Zydus Lifesciences share price today i.e. is trending at ₹1105.9, which is -8.22% down from its 52 week high and 32.36% up from its 52 week low.
What is Zydus Lifesciences's market capitalisation today?
Zydus Lifesciences market capitalisation is ₹1,09,625.67 Cr as on .
How to buy Zydus Lifesciences shares?
To buy Zydus Lifesciences shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Zydus Lifesciences trading volume today?
Zydus Lifesciences trading volume is 4.00L as on . This means that 4.00L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Zydus Lifesciences shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Zydus Lifesciences have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 54 days. This reflects platform activity only and is not investment advice.